MOTS-C (40mg)

Mitochondrial Oxidative Stress Transcription Factor C (MOTS-C) is a short peptide derived from mitochondrial DNA. This research-only compound has garnered significant interest in the scientific community for its potential implications in mitochondrial function, metabolic regulation, and stress responses. Below is detailed information regarding its biochemical properties, current research focus, and applications within a research context.

Research Context

MOTS-C was initially identified as a peptide sequence (VLSVGGVV) expressed in mitochondrial DNA. Early studies suggested its involvement in metabolic adaptation and stress resistance, particularly in mitochondrial biogenesis and energy metabolism. The peptide’s ability to mimic the effects of certain signaling pathways has prompted investigations into its potential therapeutic and research utility under controlled conditions.

Research Overview

As of available literature up to 2023, MOTS-C has been studied primarily in cellular and animal models. Research has focused on its role in modulating mitochondrial dynamics, oxidative stress responses, and metabolic processes. While preliminary findings indicate potential benefits in conditions involving mitochondrial dysfunction, it is essential to note that extensive human clinical trials are not yet established. This product is intended for academic and scientific investigation only, with no claims made regarding human or animal therapeutic applications.

Key Research Focus Areas

• Mitochondrial Function and Biogenesis: Investigation into how MOTS-C influences mitochondrial proliferation, membrane potential, and overall mitochondrial health.
• Metabolic Adaptation and Stress Resistance: Examination of its role in cellular responses to energy demands, fasting, and metabolic stress.
• Oxidative Stress and Cellular Homeostasis: Analysis of its effects on reactive oxygen species (ROS) regulation and antioxidant defense mechanisms.
• Neuroprotection and Aging: Preliminary research exploring potential neuroprotective properties in models of neurodegenerative disease or aging.
• Comparative Analysis with Other Peptides: Studies contrasting MOTS-C’s effects with other mitochondrial peptides, such as mitochondrial-targeted antioxidants or growth factors.

Safety and Compliance

MOTS-C is provided for research use only and must be handled with the same rigor as any experimental compound. Researchers are advised to follow established protocols for peptide storage, administration, and disposal in accordance with institutional guidelines. This product is not intended for human or animal consumption and does not constitute medical advice. Any experiments involving MOTS-C must adhere to ethical standards and regulatory requirements applicable to the conducting institution.

For research use only. Not for human or animal consumption.